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Backgruond. Three-dimensional conformal radiotherapy (3D-CRT) in the planning treatment of locorregional breast cancer includ-
ing the internal mammary chain is realized, in our centre, by using tangential ﬁelds with multisegments; and PA-AP ﬁelds for
nodal areas. Helical Tomotherapy (HT) is a sort of intensity-modulated radiation therapy, that uses an integrated CT scanner
during radiation which is performed helicoidally.
Purpose. To compare the dosimetric distribution of two breast radiotherapy plans: three-dimensional conformal radiotherapy vs.
Helical Tomotherapy.
Methods and materials. Six patients with stage IIIC breast cancer affecting internal mammary chain (clinically and/or histologically
conﬁrmed), were included in this study. For each patient, treatment plans were generated to compare the three-dimensional con-
formal radiotherapy (3D-CRT) against the Helical Tomotherapy (HT). CT simulation was performed in supine position with both
arms above head and external rotation. The planning target volumes (PTV) included the chest wall/whole breast, supraclavicular,
axillary, and internal mammary chain nodes. Dose prescription was 50.4Gy, in 28 fractions of 1.8Gy, to the PTV.
Results. The average V20 and V5 for heart was 7.28% and 84.94% for HT vs. 2.73% and 8.18% for 3D-CRT. The average V30, V20 and
V5 for ipsilateral lung was 19.66%, 31.47% and 92.61% for HT vs. 33.78%, 38.41% and 54.82% for 3D-CRT. The average percentage
of the contralateral lung receiving ≥5Gy was 62.41% for HT and 2.86% for 3D-CRT. The average percentage of the contralateral
breast receiving ≥5Gy was 50.33% for HT and 8.18% for 3D-CRT.
Conclusion. Tomotherapy decreases high dose irradiation in lung at the expense of a greater volume of lung and heart receiving
low-dose irradiation and higher irradiation of contralateral breast and lung. The choice of treatment plan must be individualized
for each patient based on doses in heart, and contralateral breast and lung.
http://dx.doi.org/10.1016/j.rpor.2013.03.643
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Background. Despite the fact that electronic health records are currently more and more common, not all the information
contained can be used in automatic process.
Aim. The objective of this study is to identify automatically the tumor size from the pathology reports before adjuvant radiation
therapy for breast cancer.
Methods. Sixty-eight pathology reports of patients with breast cancer treated with adjuvant radiation therapy between January
and April 2012 were used as a test dataset and 89 pathology reports from a different hospital were used as a validation set.
1507-1367/$ – see front matter
S392 reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) S391–S393
Three data mining algorithms (J48, LADtree, NaiveBayes) and a non-data mining based algorithm were used for classiﬁcation.
The selected reports were reviewed and annotated by 2 radiation oncologists according to the 7th edition TNM staging system.
The rates of coincidence between the algorithms and the manual detection were assessed by the Cochran’s Q test.
Results. The non-data mining based algorithm had the highest percentage of correctly classiﬁed cases running both the test
dataset and the validation set (96% and 99%, respectively). There were signiﬁcant differences between the results of the various
algorithms used (P=0.001). The reasons for the errors in the classiﬁcation by the algorithms were mainly due to the lack of
recognition of multifocal status and inﬂammatory disease.
Conclusions. This system based on artiﬁcial intelligence automatically enables the classiﬁcation of tumor size in breast cancer.
This tool would help saving time in the data collection, preventing errors, and improving tumor classiﬁcation as well as the
quality of the therapeutic decision.
http://dx.doi.org/10.1016/j.rpor.2013.03.644
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Introduction. Radiation therapy is an integral part in the combined treatment of breast cancer. The beneﬁt is well established in
terms of both local control and survival endpoints. Helical Tomotherapy has been proposed as an alternative to standard 3D
conformal radiotherapy.
Purpose. To evaluate dosimetric characteristics of Helical Tomotherapy for breast cancer radiotherapy.
Methods and materials. Nine patients with histologically proven breast cancer affecting internal mammary chain (clinically and/or
histologically conﬁrmed) stage IIIC, were included in this study. CT simulation scans were used to contour the planning target
volumes (PTV) including the chest wall/breast, supraclavicular, axillary, and internal mammary lymph nodes. Dose prescription
was 50/50.4, in 25/28 fractions of 2/1.8Gy, to the PTV and treatment planning objectives were to cover at least 95% of the planning
target volume with the 95% isodose. Beamlet entrance and/or exit throughout critical structures was blocked to protect the lungs,
heart, and contralateral breast.
Results. Median homogeneity index (maximum dose/prescribed dose) was 1.23 (range 1.05–1.48). Median coverage index (min-
imum dose/prescribed dose) was 0.72 (range 0.54–0.9) Median V30, V20 and V5 for ipsilateral lung was 16.72% (range 0–26.5%),
30.8% (range 10.62–40%) and 97.6% (range 64.46–100%) respectively. Median V30, V20 and V5 for contralateral lung was 0% (range
0–0.48%), 0.095% (range 0–2.58%) and 49% (range 5.84–92.38%) respectively. Median V30, V20 and V5 for heart was 1.112% (range
0–4.6%), 4% (range 0.025–15.44%) and 96.52% (range 27.3–100%) respectively. Median V20, V10 and V5 for contralateral breast was
0% (range 0–0.37%), 1.25% (range 0.1–11.82%) and 28% (range 15.53–49.4%) respectively.
Conclusion. HT offers acceptable dose distribution. This technique achieves high homogeneity and conformality, and reduces the
hot-spots in organs at risk although increasing the low dose areas However clinical advantage of using HT in breast cancer is
unknown. Further studies of long monitoring period are required.
http://dx.doi.org/10.1016/j.rpor.2013.03.645
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Introduction. Postmastectomy radiotherapy has an important role in terms of survival and quality of life in breast cancer. It has
demonstrated superior locoregional control. Women who required RTPM represent a great reconstructive challenge. Optimal
management of women who have undergone RTPM and reconstruction for breast cancer requires a multimodality approach.
Breast reconstruction can be carried out immediate or delayed. The adequate decision is based on optimize outcomes and
minimize complications. Despite patients who need radiation are more suitable for delayed reconstruction, in this study we
analyze a series of patients treated with RT in our center who undergone immediate reconstruction.
Method. We studied twenty patients treated with postmastectomy radiotherapy who underwent immediate reconstruction and
twenty patients without reconstruction from 2007 to 2012. The prescribed dose was 50Gy in 25 fractions and those who received
also boost was 16Gy in 8 fr. The implant used was tissue expander and one was directly a prosthesis. The staging most frequently
was III. The type of procedure was in all cases modiﬁed radical mastectomy and one simple mastectomy.
Results. The acute toxicity (1 month) was dermatitis Grade I and no toxicity at 6 months in the immediate reconstruction group
and dermatitis G1 and G2 in the PMRT without reconstruction group, based in the toxicity criteria of the Radiation Oncology
Therapy Group. There was nor infection neither deﬂation. In one of them was developed capsular contractured that required
